|
ACRV Acrivon Therapeutics Inc 1781174 |
| Balance Sheet |
|
Current Assets
|
188,984,000 |
|
Assets
|
214,684,000 |
|
Current Liabilities
|
14,819,000 |
|
Liabilities
|
17,792,000 |
|
Equity
|
196,892,000 |
|
Shares Out
|
30,972,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-48,309,000 |
|
Investing Cash Flow
|
-66,183,000 |
| Market Analysis |
Market Cap
|
244,989,780 |
|
Price
|
5.78 |
|
BVPS
|
6.36 |
|
PB
|
0.87 |
|
EPS
|
-2.77 |
|
PS
|
1.50 |
|
FCF
|
-114,492,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACRV documents filed with the SEC.
ACRV Filings
Clear
